Digg It - Business

Do-not-call lists are playing spoilsport to any and all of the various telema

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

rketing initiatives out there. These lists are compiled in a central database

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

and filled by people who have called in and place their own names on the list

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

In addition, there can also be do-not-call lists for single companies, if th

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

t person expressly calls in and asks them not to call. These lists must be ad

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ered to as closely as possible. The agencies planning telemarketing campaigns

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

now find quite an uphill task thanks to do-not-call lists. The consumers play

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

a big role in setting up do-not-call lists. They give telephone numbers that

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

hey want to be included in the lists. There is no denying the fact that telem

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

rketing do-not-call lists are bad news for telemarketing companies.

Those wh

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

believe in making cold calls to potential customers should now think of opti

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ng for another viable telemarketing strategy. However, from the consumers’ po

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

nt of view, telemarketing do not call lists are blessing. People who do not w

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

nt to receive these calls simply put their phone numbers on the list. To giv

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

the customers a fair degree of opportunity, majority of the states have come

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

up with an extensive National Do Not Call Registry. Both the Federal Trade Co

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

mission and the Federal Communications Commission have found several consumer

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

signing up for the telemarketing do not call lists.

So it has become compul

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ory for telemarketing companies to make sure they do not call customers whose

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

numbers are on the list; otherwise, the company can be liable for heavy fines

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/39066/diggit-Telemarketing-Do-Not-Call-Lists.html">Telemarketing Do Not Call Lists</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/39066/diggit-Telemarketing-Do-Not-Call-Lists.html]Telemarketing Do Not Call Lists[/url]

Several states have small business government grants. These are not offered by the federal government but a number of state-run development agencies provide free government grants.

This article answers the most common questions that individuals have when thinking of a new career as a mortgage broker.

Whizzing in perpetual motion the minds of those in the Online Think Tank never stop considering all sides to all issues in their quest to come up with the best decisions and solutions for mankind. Recently a topic came up which pits capitalism against socialism in the ultimate challenge as one gentleman who worked 30 years in an R and D research project is now giving it all away.

Tags

Links

Digg It - Telemarketing Do Not Call Lists

Related Articles: